Woodline Partners’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.2M | Hold |
780,442
| – | – | 0.05% | 432 |
|
|
2025
Q1 | $8.26M | Sell |
780,442
-26,470
| -3% | -$280K | 0.05% | 397 |
|
|
2024
Q4 | $13.7M | Buy |
806,912
+26,956
| +3% | +$457K | 0.09% | 283 |
|
|
2024
Q3 | $18.1M | Buy |
779,956
+25,933
| +3% | +$602K | 0.15% | 206 |
|
|
2024
Q2 | $18.4M | Sell |
754,023
-160,341
| -18% | -$3.9M | 0.18% | 176 |
|
|
2024
Q1 | $30.9M | Sell |
914,364
-155,450
| -15% | -$5.25M | 0.28% | 110 |
|
|
2023
Q4 | $33.7M | Hold |
1,069,814
| – | – | 0.37% | 76 |
|
|
2023
Q3 | $27.3M | Hold |
1,069,814
| – | – | 0.32% | 84 |
|
|
2023
Q2 | $30.7M | Buy |
1,069,814
+251,376
| +31% | +$7.21M | 0.36% | 76 |
|
|
2023
Q1 | $19.6M | Buy |
818,438
+66,107
| +9% | +$1.58M | 0.27% | 104 |
|
|
2022
Q4 | $12.8M | Sell |
752,331
-125,193
| -14% | -$2.12M | 0.17% | 166 |
|
|
2022
Q3 | $13M | Buy |
+877,524
| New | +$13M | 0.18% | 160 |
|
|
2021
Q2 | – | Sell |
-8,442
| Closed | -$349K | – | 593 |
|
|
2021
Q1 | $349K | Buy |
+8,442
| New | +$349K | 0.01% | 401 |
|
|
2020
Q4 | – | Sell |
-39,016
| Closed | -$1.67M | – | 225 |
|
|
2020
Q3 | $1.67M | Sell |
39,016
-109,067
| -74% | -$4.68M | 0.05% | 166 |
|
|
2020
Q2 | $6.92M | Buy |
+148,083
| New | +$6.92M | 0.27% | 91 |
|